MANKIND
NSE#312 by turnoverMankind Pharma Limited
Key statistics
- Open
- ₹2,488.30
- Day range
- 2,454.40 – 2,504.60
- 52-week range
- 1,909.70 – 2,674.00
- From 52w high
- -7.4%
- Volume
- 3.34L
- Turnover
- ₹82.6Cr
- Delivery
- 58.6%
- Rel volume
- 0.84×
- RSI (14)
- 60.3
- ATR (14)
- 56.53
- SMA 50
- 2,420.44
- SMA 200
- 2,287.43
20-day avg 56.5%
Performance
- 1 day
- -1.00%
- 1 week
- +7.57%
- 1 month
- +3.39%
- 3 months
- -0.45%
- 6 months
- +28.41%
- 1 year
- -6.19%
Delivery percentage
- Latest
- 58.6%
- 20-day avg
- 56.5%
- 1-year avg
- 55.9%
- Percentile
- 54th
- Range
- 7.5–93.9%
25 Sept 2026
Against its own sessions
842 sessions
Over the last 20 sessions MANKIND settled 56.5% of its traded quantity, which is above average for an NSE equity. That is in line with its own one-year average of 55.9%. The latest session ranks higher than 54% of the 842 sessions on record for it.
What delivery percentage measuresScan the whole market on delivery
Fundamentals
- Market cap
- ₹1,02,225 Cr
- P/E (TTM)
- 49.44
- EPS (TTM)
- ₹50.06
- Shares outstanding
- 41.30Cr
- Listed
- 9 May 2023
Q1 FY27
Classification
- Macro sector
- Healthcare
- Sector
- Healthcare
- Industry
- Pharmaceuticals & Biotechnology
- Basic industry
- Pharmaceuticals
NSE publishes no history for this taxonomy, so it is today’s classification rather than the one that held in the past.
Growthlatest filed quarter Q1 FY27
- Revenue YoY
- +12.89%
- Profit YoY
- +29.12%
- Revenue QoQ
- +17.07%
- Profit QoQ
- +2.62%
- Interest cost YoY
- -1.80%
Compound growth
| Annualised | 2y | 3y | 4y | 5y | 6y | 7y |
|---|---|---|---|---|---|---|
| Revenue | +17.6% | — | — | — | — | — |
| Profit | +1.9% | — | — | — | — | — |
Trailing-twelve-month figures against the same measure that many years earlier, on one reporting basis throughout. Blank where the filed history is too short or either end of the window was a loss — never a number built from less.
About
- ISIN
- INE634S01028
- Series
- EQ
- History from
- 9 May 2023
- Sessions
- 842
Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 25 Sept 2026.